Diabetes in relation to biliary tract cancer and stones: A population-based study in Shanghai, China

British Journal of Cancer

Volumn 103, Issue 1, 2010, Pages 115-119

  Shebl, F M ^a   Andreotti, G ^a   Rashid, A ^b   Gao, Y T ^c   Yu, K ^a   Shen, M C ^d   Wang, B S ^d   Li, Q ^a   Han, T Q ^e   Zhang, B H ^f   Fraumeni, J F ^a   Hsing, A W ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c SHANGHAI CANCER INSTITUTE   (China)

^d FUDAN UNIVERSITY   (China)

^e SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^f SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

biliary stones; biliary tract cancers; diabetes; mediation modelling

Indexed keywords

HIGH DENSITY LIPOPROTEIN;

ARTICLE; BILIARY TRACT CANCER; BODY MASS; CANCER RISK; CHINA; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GALLBLADDER CANCER; GALLSTONE; HUMAN; INTERVIEW; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; ADULT; AGED; BILIARY TRACT TUMOR; BLOOD; GALLBLADDER TUMOR; MIDDLE AGED; RISK FACTOR;

ADULT; AGED; BILIARY TRACT NEOPLASMS; BODY MASS INDEX; CHINA; DIABETES COMPLICATIONS; FEMALE; GALLBLADDER NEOPLASMS; GALLSTONES; HUMANS; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; RISK FACTORS;

EID: 77954176765     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605706     Document Type: Article

References (29)

1. Abrams JJ, Ginsberg H, Grundy SM (1982) Metabolism of cholesterol and plasma triglycerides in nonketotic diabetes mellitus. Diabetes 31: 903-910
2. Adami HO, Chow WH, Nyren O, Berne C, Linet MS, Ekbom A, Wolk A, McLaughlin JK, Fraumeni Jr JF (1996) Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst 88: 1472-1477
3. Andreotti G, Chen J, Gao YT, Rashid A, Chang SC, Shen MC, Wang BS, Han TQ, Zhang BH, Danforth KN, Althuis MD, Hsing AW (2008) Serum lipid levels and the risk of biliary tract cancers and biliary stones: a population-based study in China. Int J Cancer 122: 2322-2329 (Pubitemid 351542338)
4. Attili AF, Capocaccia R, Carulli N, Festi D, Roda E, Barbara L, Capocaccia L, Menotti A, Okolicsanyi L, Ricci G, Lalloni L, Mariotti S, Sama C, Scafato E (1997) Factors associated with gallstone disease in the MICOL experience. Multicenter Italian Study on Epidemiology of Cholelithiasis. Hepatology 26: 809-818
5. Benitez S, Camacho M, Bancells C, Vila L, Sanchez-Quesada JL, Ordonez-Llanos J (2006) Wide proinflammatory effect of electronegative low-density lipoprotein on human endothelial cells assayed by a protein array. Biochim Biophys Acta 1761: 1014-1021
6. Carey MC (1993) Pathogenesis of gallstones. Am J Surg 165: 410-419
7. Chapman BA, Wilson IR, Frampton CM, Chisholm RJ, Stewart NR, Eagar GM, Allan RB (1996) Prevalence of gallbladder disease in diabetes mellitus. Dig Dis Sci 41: 2222-2228
8. De Santis A, Attili AF, Ginanni Corradini S, Scafato E, Cantagalli A, De Luca C, Pinto G, Lisi D, Capocaccia L (1997) Gallstones and diabetes: a case-control study in a free-living population sample. Hepatology 25: 787-790
9. Feldman M, Feldman Jr M (1954) The incidence of cholelithiasis, cholesterosis, and liver disease in diabetes mellitus: an autopsy study. Diabetes 3: 305-307
10. Festi D, Dormi A, Capodicasa S, Staniscia T, Attili AF, Loria P, Pazzi P, Mazzella G, Sama C, Roda E, Colecchia A (2008) Incidence of gallstone disease in Italy: results from a multicenter, population-based Italian study (the MICOL project). World J Gastroenterol 14: 5282-5289
11. Goldberg IJ (2001) Clinical review 124: diabetic dyslipidemia: causes and consequences. J Clin Endocrinol Metab 86: 965-971
12. Grainge MJ, West J, Solaymani-Dodaran M, Aithal GP, Card TR (2009) The antecedents of biliary cancer: a primary care case-control study in the United Kingdom. Br J Cancer 100: 178-180
13. Hsing AW, Gao YT, Han TQ, Rashid A, Sakoda LC, Wang BS, Shen MC, Zhang BH, Niwa S, Chen J, Fraumeni Jr JF (2007) Gallstones and the risk of biliary tract cancer: a population-based study in China. Br J Cancer 97: 1577-1582 (Pubitemid 350175843)
14. Hsing AW, Rashid A, Devesa SS, Fraumeni Jr JF (2006) Biliary tract cancer. In Cancer Epidemiology and Prevention, Schottenfeld D, Fraumeni Jr JF (eds) 3rd edn, pp 787-800. Oxford University Press Inc.: New York
15. Hsing AW, Sakoda LC, Rashid A, Andreotti G, Chen J, Wang BS, Shen MC, Chen BE, Rosenberg PS, Zhang M, Niwa S, Chu L, Welch R, Yeager M, Fraumeni Jr JF, Gao YT, Chanock SJ (2008a) Variants in inflammation genes and the risk of biliary tract cancers and stones: a population-based study in China. Cancer Res 68: 6442-6452
16. Hsing AW, Sakoda LC, Rashid A, Chen J, Shen MC, Han TQ, Wang BS, Gao YT (2008b) Body size and the risk of biliary tract cancer: a population-based study in China. Br J Cancer 99: 811-815
17. Joint Committee for Developing Chinese Guidelines on Prevention and Treatment of Dyslipidemia in Adults (2007) [Chinese guidelines on prevention and treatment of dyslipidemia in adults]. Zhonghua Xin Xue Guan Bing Za Zhi 35: 390-419
18. Jorgensen T (1989) Gall stones in a Danish population. Relation to weight, physical activity, smoking, coffee consumption, and diabetes mellitus. Gut 30: 528-534
19. Loria P, Dilengite MA, Bozzoli M, Carubbi F, Messora R, Sassatelli R, Bertolotti M, Tampieri A, Tartoni PL, Cassinadri M, Ciana MD, Contemori M, Save N, Sordi B, Alimenti G, Fabrizi F, Buciuni A, Carulli N (1994) Prevalence rates of gallstone disease in Italy. The Chianciano population study. Eur J Epidemiol 10: 143-150
20. MacKinnon DP, Lockwood CM, Brown CH, Wang W, Hoffman JM (2007) The intermediate endpoint effect in logistic and probit regression. Clin Trials 4: 499-513
21. Pagliarulo M, Fornari F, Fraquelli M, Zoli M, Giangregorio F, Grigolon A, Peracchi M, Conte D (2004) Gallstone disease and related risk factors in a large cohort of diabetic patients. Dig Liver Dis 36: 130-134
22. Preacher KJ, Hayes AF (2008) Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods 40: 879-891
23. Singh V, Zaidi SA, Singh VS (1997) Lipids in biliary lithogenesis. J Pak Med Assoc 47: 253-255
24. Stone BG, Van Thiel DH (1985) Diabetes mellitus and the liver. Semin Liver Dis 5: 8-28
25. Volzke H, Baumeister SE, Alte D, Hoffmann W, Schwahn C, Simon P, John U, Lerch MM (2005) Independent risk factors for gallstone formation in a region with high cholelithiasis prevalence. Digestion 71: 97-105
26. von Eckardstein A, Hersberger M, Rohrer L (2005) Current understanding of the metabolism and biological actions of HDL. Curr Opin Clin Nutr Metab Care 8: 147-152
27. Welzel TM, Graubard BI, El-Serag HB, Shaib YH, Hsing AW, Davila JA, McGlynn KA (2007) Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin Gastroenterol Hepatol 5: 1221-1228
28. WHO Expert Consultation (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363: 157-163
29. WHO/IASO/IOTF (2000) The Asia-Pacific Perspective: Redefining Obesity and its Treatment Health Communications Australia Pty Ltd (Full document available from: http://www.wpro.who.int/NR/rdonlyres/0A35147B-B1D5-45A6-9FF2-F7D86608A4DE/ 0/Redefiningobesity.pdf) Australia, Melbourne